G6PD and methemoglobinemia: The first was the reporting of severe adverse effects, including methemoglobinemia and hemolytic anemia occurring in glucose-6-phosphate dehydrogenase (G6PD)-deficient patients.26,27 The second reason was perhaps due to the introduction of a new drug, chloroquine, which was relatively safe and highly potent.